- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05012930
Effects of Complementary Feeding on Infant Growth and Gut Health (MINT)
This study plans to learn more about how consuming different foods during the time of early complementary feeding (~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut. The results from this study will potentially help to support future recommendations and dietary guidance for infant feeding practices.
The three primary aims include:
Aim 1. Identify the impact of dietary patterns with different protein-rich foods on infant growth.
Aim 2. Identify the impact of dietary patterns with different protein-rich foods on infant gut microbiota development.
Aim 3. Identify gut microbial taxa and genes that affect infant growth.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of Colorado Anschutz Medical Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Full term;
- Generally healthy without conditions that would affect protein metabolism or growth
- No previous complementary food exposure
- Vaginal delivery
- No prior exposure of antibiotics during delivery or after birth
- Able to consume study foods
- Single birth.
Exclusion Criteria:
- Pre-term infants.
- Having conditions that would affect normal growth
- Had complementary foods prior to the start of the study
- Not willing to consume the complementary foods provided
- Antibiotics exposure during delivery or from birth to 5 months of life
- Multiple births
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study Provided Diet - Meat
A group of complementary foods provided to participants by researchers.
|
Commercially available baby foods
|
Experimental: Study Provided Diet - Plant
A group of complementary foods provided to participants by researchers.
|
Commercially available baby foods
|
Experimental: Study Provided Diet - Dairy
A group of complementary foods provided to participants by researchers.
|
Commercially available baby foods
|
Placebo Comparator: Traditional Diet
No study foods provided to participants by researchers.
Participants will eat a typical diet provided by caregivers.
|
Caregiver will provide participant with usual foods from the home
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: Over 6 months
|
Measured in kg
|
Over 6 months
|
Length
Time Frame: Over 6 months
|
Measured in cm
|
Over 6 months
|
Head Circumference
Time Frame: Over 6 months
|
Measured in cm
|
Over 6 months
|
Body composition
Time Frame: Over 6 months
|
Body fat mass, fat-free mass measured by stable isotopes
|
Over 6 months
|
Gut Microbiome
Time Frame: Over 6 months
|
Gut microbiota structure by 16S sequencing
|
Over 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total calories in breast milk
Time Frame: Over 6 months
|
Measured in kcal/100 mL
|
Over 6 months
|
Total carbohydrates in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
Total protein in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
Total fat in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)
Time Frame: Over 6 months
|
Measured in ng/mL
|
Over 6 months
|
Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)
Time Frame: Over 6 months
|
Measured in ng/mL
|
Over 6 months
|
Serum c-reactive protein (CRP-hs)
Time Frame: Over 6 months
|
Measured in mg/L
|
Over 6 months
|
Plasma alpha 1-acid glycoprotein (AGP)
Time Frame: Over 6 months
|
Measured in mg/L
|
Over 6 months
|
Dietary intake
Time Frame: Over 6 months
|
3 day dietary recall with results generated by NDSR software
|
Over 6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20-2232
- 1R01DK126710-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gut Microbiome
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
University College CorkAIT Austrian Institute of Technology GmbHNot yet recruiting
-
Evolve BioSystems, Inc.University of California, DavisCompletedGut MicrobiomeUnited States
-
State University of New York at BuffaloCompleted
-
Access Business GroupCompletedGut MicrobiomeUnited States
-
Washington University School of MedicineCompleted
-
Evolve BioSystems, Inc.Terminated
-
Evolve BioSystems, Inc.CompletedInfant Gut MicrobiomeUnited States
Clinical Trials on Baby Foods - Meat
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingGut Microbiome | Neurodevelopment | Linear GrowthUnited States
-
University of ExeterNIHR Exeter Clinical Research Facility; Marlow Foods LtdCompleted
-
University of HelsinkiActive, not recruitingCardiovascular Diseases | Colorectal Cancer | Type2 DiabetesFinland
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Professor Lars Ove DragstedCompleted
-
Hadassah Medical OrganizationCompleted
-
Pennington Biomedical Research CenterAlliance for Potato Research and EducationCompleted
-
National Institute of Diabetes and Digestive and...Completed
-
Institut National de la Recherche AgronomiqueCentre de Recherche en Nutrition Humaine d'AuvergneCompleted
-
UCSF Benioff Children's Hospital OaklandNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedInflammation | Cardiovascular Disease | Insulin Resistance | DyslipidemiaUnited States